Label-Free Prediction of EGFR Mutation Status Using Fluorescence Lifetime Imaging and Deep Learning in Lung Adenocarcinoma.

Deep learning combined with label-free fluorescence lifetime imaging achieves a 0.966 accuracy in predicting EGFR mutations in lung adenocarcinoma tissues.

• Why it matters: Accurate, rapid, and noninvasive mutation detection is crucial for guiding targeted therapies in non-small cell lung cancer, yet current methods are costly, time-consuming, and tissue-destructive.
• What they did: The study developed a deep learning approach that analyzes unstained, formalin-fixed tissue using fluorescence lifetime imaging, eliminating the need for traditional staining or molecular testing on 150 samples.
• The result: This method enables fast, nondestructive mutation prediction with high accuracy, potentially reducing clinical costs and turnaround time, and facilitating quicker development of personalized treatment strategies.